FLUDARABINE AND CYCLOPHOSPHAMIDE (FC) VERSUS CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISONE (CVP) AS FIRST LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Ionita, H. [1 ]
Chreveresan, L. [1 ]
Mihaescu, R. [1 ]
Ionita, I. [1 ]
Isac, A. [1 ]
Cheveresan, M. [2 ]
Oros, D. [1 ]
Iordache, M. [1 ]
Musta, I. [1 ]
Basa, N. [1 ]
Delamarian, M. [2 ]
机构：
[1] Univ Med & Farm Timisoara, Timisoara, Romania
[2] Cty Hosp, Dept Hematol, Timisoara, Romania
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1203
引用
收藏
页码：468 / 468
页数：1
相关论文
共 50 条
  • [1] FLUDARABINE AND CYCLOPHOSPHAMIDE (FC) VERSUS CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISONE(CVP) AS FIRST LINE THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Ionita, H.
    Ionita, I.
    Cheveresan, L.
    Ionita, M.
    Delamarian, M.
    Racz, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 599 - 600
  • [2] USEFULNESS OF CYCLOPHOSPHAMIDE-VINCRISTINE-PREDNISONE (CVP) THERAPY IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    OKEN, MM
    KAPLAN, ME
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 382 - 382
  • [3] USEFULNESS OF CYCLOPHOSPHAMIDE-VINCRISTINE-PREDNISONE (CVP) THERAPY IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    OKEN, MM
    KAPLAN, ME
    BLOOD, 1977, 50 (05) : 202 - 202
  • [4] A UK Cost-Effectiveness Analysis Comparing First Line Treatment with Rituximab in Combination with Fludarabine and Cyclophosphamide Versus Fludarabine and Cyclophosphamide Alone in Chronic Lymphocytic Leukemia (CLL) Patients
    Papadakis, Konstantinos
    Oscier, David
    Carr, Emma S. C.
    Lewis, Gavin
    Aultman, Rick
    BLOOD, 2008, 112 (11) : 834 - 834
  • [5] FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB IN FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): RETROSPECTIVE STUDY
    Ionita, H.
    Ionita, I.
    Cheveresan, M.
    Ionita, M.
    Calamar, D.
    Ionita, C. O.
    Oros, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 526 - 526
  • [6] Fludarabine, cyclophosphamide and rituximab (FCR) in front line treatment of patients with chronic lymphocytic leukemia (CLL)
    Grifi, Fatiha
    Bougherira, Soraya
    Djenouni, Amel
    LEUKEMIA & LYMPHOMA, 2017, 58 : 94 - 94
  • [7] Therapy with fludarabine, cyclophosphamide and rituximab (FCR) for relapsed or untreated progressive chronic lymphocytic leukemia (CLL). A single center experience.
    Pavlovsky, Carolina
    Pavlovsky, Ntiago
    Pardo, Maria L.
    Sapia, Sandra
    Monreal, Maricla
    Corrado, Claudia
    Pavlovsky, Miguel A.
    Fernandez, Isolda
    Juni, Mariana
    BLOOD, 2006, 108 (11) : 329B - 329B
  • [8] Fludarabine (FAMP) and cyclophosphamide (CTX) combination in chronic lymphocytic leukemia (CLL).
    Gonzalez, H
    Cazin, B
    Dighiero, G
    Merle-Béral, H
    Vernant, JP
    Binet, JL
    Maloum, K
    BLOOD, 1998, 92 (10) : 277B - 277B
  • [9] Fludarabine (FAMP) and cyclophosphamide (CTX) therapy in chronic lymphocytic leukemia (CLL)
    OBrien, S
    Kantarjian, H
    Beran, M
    Lerner, S
    Gilbreath, J
    Keating, MJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 453 - 453
  • [10] Fludarabine (FAMP) and cyclophosphamide (CTX) therapy in chronic lymphocytic leukemia (CLL).
    OBrien, S
    Kantarjian, H
    Beran, M
    Freireich, E
    Komblau, S
    Koller, C
    Lerner, S
    Gilbreath, J
    Keating, M
    BLOOD, 1996, 88 (10) : 1910 - 1910
12345